BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7,807
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. BioNTech SE - ADR market cap is $20.07B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioNTech SE - ADR 52 week high is $124.00 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioNTech SE - ADR 52 week low is $79.52 as of November 22, 2026.
BioNTech SE - ADR stock price today is $80.96.
BioNTech SE - ADR stock price yesterday was $81.38.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. BioNTech SE - ADR's P/E ratio is -11.82.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. BioNTech SE - ADR P/B ratio is 0.9977.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. BioNTech SE - ADR 50-day moving average is $91.52.